# MicroRNA as Markers in Testicular Cancer

> **NCT04914026** · — · RECRUITING · sponsor: **Haukeland University Hospital** · enrollment: 350 (estimated)

## Conditions studied

- Testicular Germ Cell Cancer
- Seminoma
- Non-Seminoma Testicular Cancer
- Stage I Testicular Cancer
- Stage II Testicular Cancer
- Stage III Testicular Cancer
- Stage IV Testicular Cancer
- Relapse Testicular Cancer

## Interventions

- **OTHER:** Biomarker analysis

## Key facts

- **NCT ID:** NCT04914026
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-12-31
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2022-08-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04914026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04914026, "MicroRNA as Markers in Testicular Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04914026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
